The UK government has provided an update on its contingency planning surrounding the possibility of a so-called “no deal” Brexit, including measures affecting pharmaceuticals.
On Tuesday, the British Parliament is set to vote on an agreed set of transitional arrangements for trade with the EU after March 29, 2019. If the government cannot secure support for the deal, severe disruption to cross-border trade would remain possible.
British health secretary Matt Hancock said that, should the UK leave without a trade deal in place, the government would use airplanes and fast-track trucks to ensure medicines can bypass any customs delays.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze